# \[e-drug\] Generic quality (cont) **URL:** \ **Category:** e-drug\ **Created:** [February 27, 2001, 5:23am UTC](https://talk.edrugplus.org/t/e-drug-generic-quality-cont/10504 "2001-02-27T05:23:42Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![msmith](https://avatars.discourse-cdn.com/v4/letter/m/aca169/32.png) [@msmith](https://talk.edrugplus.org/u/msmith)\ **Post date:** [February 27, 2001, 5:23am UTC](https://talk.edrugplus.org/t/e-drug-generic-quality-cont/10504/1 "2001-02-27T05:23:42Z")
E-drug: Generic quality (cont) --------------------------------------------- Thanks Kirsten. I will follow the leads you gave me. What I am concerned about are generic medicines produced in developing countries. The issue for me is not whether there are legal procedures to ensure quality but if there is evidence of sub-quality and bad quality of those drugs. Are there studies, apart from the ones you mentioned and R. Laing mentioned, on quality of generic drugs produced in developing countries? There was one by WHO recently which sounded alarming and lately there was alarms from India. Mohga Dr. Mohga Kamal Smith Health policy advisor Policy Department Oxfam GB 274 Banbury Rd Oxford OX2 7DZ Tel + 44 (0) 1865 312290 Fax +44 (0) 1865 312245 E mail msmith@Oxfam.org.uk -- Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'. Mail administrative requests to `majordomo@usa.healthnet.org'. For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.